Skip to search formSkip to main contentSkip to account menu

OPB 9195

Known as: OPB-9195 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ThiadiazolesThiazolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Efficient generation of sequences of dense linear algebra through auto-tuning
It is rare for a programmer to solve a numerical problem with a single library call; most problems require a sequence of calls… 
2009
2009
Impaired gastric ulcer healing in diabetic mice: role of methylglyoxal.
Methylglyoxal is a reactive dicarbonyl compound produced from cellular glycolytic intermediates that reacts non-enzymatically… 
2006
2006
Novel therapeutic strategies for reducing arterial stiffness
British Journal of Pharmacology (2006) 148, 881–883. doi:10.1038/sj.bjp.0706805 
Review
2003
Review
2003
Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product…
2003
2003
CHAINS OF EDGE-SHARING OPb4 TETRAHEDRA IN THE STRUCTURE OF Pb4O(VO4)2 AND IN RELATED MINERALS AND INORGANIC COMPOUNDS
Nous avons resolu la structure cristalline du compose Pb 4 O(VO 4 ) 2 en utilisant des cristaux prepares par reactions a l'etat… 
2003
2003
An inhibitor of advanced glycation end product formation reducesNϵ-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats
Abstract Background: An inhibitor of advanced glycation, OPB-9195, retards the progression of nephropathy in Otsuka Long-Evans… 
2003
2003
An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
BACKGROUND An inhibitor of advanced glycation, OPB-9195, retards the progression of nephropathy in Otsuka Long-Evans Tokushima… 
2002
2002
Inhibition of the development of experimental diabetic neuropathy by suppression of AGE formation with a new antiglycation agent
Highly Cited
2001
Highly Cited
2001
Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Background Nonenzymatic glycation of neural proteins and their end‐products (advanced glycation end‐products, AGE) have been… 
Highly Cited
1999
Highly Cited
1999
Carbonyl compounds cross‐link cellular proteins and activate protein‐tyrosine kinase p60c‐Src
Glyoxal, a dicarbonyl compound, is produced under oxidative stress by the autoxidation of glucose and reacts with the protein… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)